2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Pathology, Serologic Tests, Bioinformatics, Cell Expansion, Computational Biology, Emerging Technologies, Profiling, Treatment Considerations, Drug Development, Therapy Sequence, Biological Therapies, Antibody Therapy, Transplantation, Immunotherapy, Monoclonal Antibody Therapy, Non-Biological Therapies, Chemotherapy, Adverse Events, Biological Processes, Apoptosis, Pathogenesis, Hematopoiesis, Immune Mechanism, Microbiome, Molecular Biology, Diseases, Immunology, GVHD, Neutropenia, Infectious Diseases, Bacterial, Lymphoid Malignancies, Lymphoid Leukemias, Plasma Cell Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, Study Population, Human, Adult, Animal Model
PAPER

5858 Dietary protein restriction causes persistent hematopoietic stem and progenitor cell mobilization defects despite nutritional refeeding

Kalil Auzier Martins Costa, PhD, Carlos Eduardo da Silva Gonçalves, PhD2, Edson Naoto Makiyama, MS3, Maura Lima Pereira Bueno, PhD4, Sandra Pinho, PhD5, Ricardo Ambrósio Fock, PhD6
1 University of Illinois Chicago, Chicago, Illinois, United States, University of São Paulo, Sao Paulo, Sao Paulo, Brazil
2 University of São Paulo, Sao Paulo, Sao Paulo, Brazil
3 University of São Paulo, Sao Paulo, Sao Paulo, Brazil
4 University of Illinois Chicago, Chicago, Illinois, United States
5 University of Illinois Chicago, Chicago, Illinois, United States
6 University of São Paulo, Sao Paulo, Sao Paulo, Brazil

Introduction: Mobilized hematopoietic stem and progenitor cells (HSPCs) have emerged as the most common source of stem cells for hematopoietic transplantation, yet this procedure remains ineffective in a subset of patients. Although nutritional status influences hematopoiesis, the impact of dietary protein restriction on HSPC mobilization remains unexplored. Previously, our group demonstrated that dietary protein deficiency impairs both HSPCs and the stromal components that support the bone marrow niche. Here, we investigated whether protein restriction impairs granulocyte colony-stimulating factor (G-CSF)-induced HSPC mobilization and whether nutritional refeeding restores normal HSPC function.

Methods: Young male C57BL/6J mice (Ethics Committee approval: 668/2023) were maintained on either a control diet (12% protein), a low-protein (LP; 2% protein) diet for 4 weeks, or a refeeding (RF) regimen consisting of 4 weeks of LP followed by 4 weeks of the control diet. All diets were isocaloric and used Casein as the protein source to ensure consistency across groups. Mice received recombinant human G-CSF (rhG-CSF; filgrastim) for four consecutive days before analysis. Phenotypic hematopoietic stem cell (HSC; Lin-CD90.1+Sca1+cKIT+), common lymphoid progenitor (CLP; Lin-CD135-CD127LowSca1+cKIT+), common myeloid progenitor (CMP; Lin-CD135-cKIT+CD34+CD16/32-), granulocyte–monocyte progenitor (GMP; Lin-CD135-cKIT+CD34+CD16/32+) and megakaryocyte–erythroid progenitor (MEP; Lin-CD135-cKIT+CD34-CD16/32-) mobilization was evaluated by flow cytometry, while bone marrow progenitor function, soluble niche factors, and HSPCs gene expression were assessed using methylcellulose colony assays, ELISA, and quantitative PCR.

Results: Dietary protein deficiency caused an approximately two-and-a-half-fold reduction in overall leukocyte cellularity in peripheral blood (P=0.0061) and bone marrow (P=0.0007). Interestingly, refeeding quantitatively restored these hematologic parameters, although HSC frequency did not fully return to control levels. Despite recovery of bone marrow HSC, CMP, CLP, GMP, and MEP frequencies after refeeding, G-CSF–induced mobilization did not match that observed in control mice. This incomplete normalization under G-CSF, despite restored marrow cellularity, prompted us to investigate adhesion pathways as potential regulators of HSPC trafficking. LP led to a markedly reduction in the expression of the adhesion molecules CXCR4 (P=0.0229), VCAM1 (P<0.0001), and CD49e (P<0.0001) on HSPCs. Notably, refeeding restored CD49e expression, but failed to normalize CXCR4 (P=0.0067) and VCAM1 (P<0.0001), which remained significantly downregulated, indicating incomplete recovery of key pathways regulating HSPC trafficking. Refeeding also failed to restore soluble stem cell factor (SCF, 62.97 ± 25.54 pg/mL) to control (247.5 ± 107.2 pg/mL) and LP (266.2 ± 151.1 pg/mL) levels, consistent with persistent alterations in the hematopoietic niche. Functionally, HSPCs from refed mice exhibited reduced clonogenicity, showing an approximately 15% decrease compared with the control group, while maintaining the frequency of both long- and short-term hematopoietic stem cells, suggesting a shift toward preservation of stem cell identity at the expense of clonogenic expansion. To validate the possible mechanisms underlying this effect during refeeding, we evaluated gene expression in rhG-CSF-stimulated bone marrow HSPCs. Gene expression analyses revealed increased Fn1 and Rptor expression, together with reduced Akr1b3in the refeeding group compared to the control, consistent with persistent extracellular matrix remodeling and altered nutrient-sensing and metabolic programs following nutritional recovery.

Conclusion: Overall, our data reveal that dietary protein restriction induces durable defects in G-CSF-mediated HSPC mobilization that persist despite restoration of dietary protein intake. These findings suggest that nutritional recovery does not fully reverse functional and molecular alterations in HSPCs and the bone marrow niche. Prior nutritional status should therefore be taken into account when optimizing protocols for hematopoietic stem cell mobilization strategies for hematopoietic transplantation.

Kalil Auzier Martins Costa, PhD: No relevant conflicts of interest to declare.